Global Kidney Commercial Strategy Director

Vertex US Distribution; Boston (MA); Ibrido; USD 261.000 - 391.000; Tempo pieno

Vantaggi offerti da questo lavoro

Medical benefits

Dental & Vision

Paid time off

Educational assistance

Commuting subsidy

401(k)

Descrizione del lavoro

Vertex is seeking an Executive Director, Global Commercial Strategy for the Kidney portfolio (Pove) to lead global commercial strategy across IgAN and pMN. This senior role will partner with Development, Medical, Regulatory, and commercial teams to shape launch sequencing, evidence needs, and lifecycle management for povetacicept in kidney indications.

The role will drive U.S. launch readiness, tie market access and patient impact to strategic investments, and build a high-performing kidney

Competenze

• Extensive biopharmaceutical commercial experience, including global strategy and lifecycle management.
• Proven experience leading global launches for specialty or rare diseases.
• Strong strategic thinking, analytical abilities, and communication skills.
• Experience in nephrology or kidney indications is strongly preferred.

Mansioni

• Co-lead the Kidney Program Team, setting strategy and priorities.
• Own global commercial strategy across IgAN and pMN.
• Lead US IgAN launch readiness and global launches.
• Shape development plans and commercial development activities.
• Build understanding of IgAN and pMN markets and access dynamics.
• Collaborate with Development, Medical, Regulatory, Value & Access, and other functions.
• Communicate recommendations to senior leaders.
• Build and lead a high-performing kidney commercial team.

Conoscenze

Global commercial strategy

Launch strategy

Cross-functional leadership

Nephrology experience

Formazione

Bachelor's degree in business, life sciences, healthcare

MBA or advanced degree preferred

Descrizione del lavoro

Vertex is seeking an Executive Director, Global Commercial Strategy for the Kidney portfolio (Pove) to lead global commercial strategy across IgAN and pMN. This senior role will partner with Development, Medical, Regulatory, and commercial teams to shape launch sequencing, evidence needs, and lifecycle management for povetacicept in kidney indications.

The role will drive U.S. launch readiness, tie market access and patient impact to strategic investments, and build a high-performing kidney